Cure SMA is committed to supporting the most promising SMA research, with over $62 million funded in our 30-year history.
Each year, Cure SMA issues requests for proposals in three major research areas:
- Basic research, to investigate the causes and biology of SMA, revealing new and more effective ways of making drugs.
- Drug discovery, to convert these basic research ideas into new drug candidates.
- Clinical care, to improve the quality of life for SMA patients today.
- Newborn screening, to facilitate the ability of state laboratories to implement and conduct newborn screening for SMA.
Our basic research program is directed by our Scientific Advisory Board, our drug discovery program by our Translational Advisory Council, and our clinical care program by our Medical Advisory Council—all groups of independent experts who carefully evaluate each proposal for scientific excellence and relevance to the Cure SMA mission.
Cure SMA’s research model is intended to attract industry and government funding for clinical trials. Thus, we do not typically issue RFPs in this area. Instead, we focus on clinical trial readiness, infrastructure, and on connecting researchers with potential study participants.
For general questions on our research funding model and RFP process for basic research or drug discovery, please email email@example.com. For questions on clinical care funding, please contact firstname.lastname@example.org.